New Pub! "Medical Cannabis Dosing Trajectories of Patients" in @clinthe!
We analyzed THC & CBD dosing in 16,000+ NY patients, finding 6 trajectories. Real-world insights to guide providers, patients, & policymakers.
sciencedirect.com/science/ar…
#MedicalCannabis #THC #CBD @NORCNews
34
All interested in cannabis regulatory policy need to check this new interactive systematic review tool! Amazing work by @eric_esevigny #LxAddictions22
Just presented Cannabis Liberalization Evidence and Gap Map presented at #LxAddictions2022. Online and fully interactive tool: eppi.ioe.ac.uk/cms/Portals/3…. Check it out! @NIDAnews @gsucjc
4
Alexandra F Kritikos, PhD retweeted
This week we held the 15th Annual International Society for the Study of Drug Policy Conference in Lisbon. It was such a treat to see everyone and to discuss and debate the latest #DrugPolicy issues & scholarship.
🌍🤗🌎🤗🌍
#ISSDP2022
So happy to be back in Lisbon! Excited to present and also learn about new drug policy research happening around the world at #ISSDP and #LxAddictions22!
I gotta say, today was a good day:
Voted: ✔️
Presented at #APHA2022: ✔️
Alexandra F Kritikos, PhD retweeted
How does one transition from econometrician to influencer? And is it easier if one is an applied econometrician?
Alexandra F Kritikos, PhD retweeted
Mentors, never underestimate the power of telling someone you mentor that they are on track to achieving their goals.
It may be obvious to you, but far less clear to the person who you mentor, and your words can have impact in building confidence and sense of belonging.
Our study using point-of-sale data from tens of thousands medical cannabis patients finds considerable variability in patient product choice, even for patients with the same condition. Now live @JAMANetworkOpen! ja.ma/3QG3MwE @PaculaRosalie @JAMANetwork @SchaefferCenter
Alexandra F Kritikos, PhD retweeted
Yesterday was my last day of working at Google. Perhaps this comes as surprise to you twitter folks, as I haven't widely announced that I left academia to try something new. Here's what I learned in 9 months as a Data Analyst who (temporarily) left Astronomy for Big Tech. 1/n
One of my greatest pleasures at @TheHellerSchool was working as a TA for Dr. Altman. Learned so much from his brilliance and mentorship!
Dr. Stuart Altman, who was named 10 years ago as the first-ever chair of Health Policy Commission board, announced Wednesday he is stepping down from that role. bizjournals.com/boston/news/…
1
Alexandra F Kritikos, PhD retweeted
Last day of #RSMj2022. A panel of US and Australian researchers will discuss methods being developed to better address measurement issues with #medicalcannabis use. @PaculaRosalie @AFKritikos @SchaefferCenter @MyfGraham @NathanCantor2 @mcmasters
Alexandra F Kritikos, PhD retweeted
Work from @USC used point-of-sale invoice data from medical cannabis patients at local dispensaries to examine trends in #THC and #CBD potency purchased by the individual over time. @AFKritikos @PaculaRosalie #RSMj2022
Alexandra F Kritikos, PhD retweeted
: NEW WHITE PAPER w/colleagues Seema Pessar, Joy Zhu, @AFKritikos and @RosannaSmart suggests current proposal to legalize #cannabis should do more to regulate high-potency products like edibles and vape cartridges. (1/7) @SchaefferCenter @USCPrice healthpolicy.usc.edu/researc…
Alexandra F Kritikos, PhD retweeted
Research from @USC @BrandeisU and @MA_Cannabis explores whether past recreational cannabis use can predict current alcohol and cannabis co-use in medical cannabis patients. @AFKritikos @PaculaRosalie @JulieKJohnson #RSMj2022
If you're attending @AcademyHealth #ARM22 & interested in cannabis use /dosing, come view our poster @ the late-breaking abstract session! @PaculaRosalie
📅June 6, 3-4 PM EST
✨ Results highlight the need for efficacy research relating to current use of cannabis products
1
2
Some people talk to themselves, I talk to my code #econproblems @AcademicChatter
1
1














